Copyright Reports & Markets. All rights reserved.

Global OPO-containing Infant Formulas Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global OPO-containing Infant Formulas Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Cow Milk Formula
    • 1.3.3 Goat Milk Formula
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global OPO-containing Infant Formulas Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 0 - 6 Month
    • 1.4.3 6 - 12 Month
    • 1.4.4 12 - 36 Month
  • 1.5 Global OPO-containing Infant Formulas Market Size & Forecast
    • 1.5.1 Global OPO-containing Infant Formulas Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global OPO-containing Infant Formulas Sales Quantity (2021-2032)
    • 1.5.3 Global OPO-containing Infant Formulas Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BiosTime
    • 2.1.1 BiosTime Details
    • 2.1.2 BiosTime Major Business
    • 2.1.3 BiosTime OPO-containing Infant Formulas Product and Services
    • 2.1.4 BiosTime OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BiosTime Recent Developments/Updates
  • 2.2 Nutriben
    • 2.2.1 Nutriben Details
    • 2.2.2 Nutriben Major Business
    • 2.2.3 Nutriben OPO-containing Infant Formulas Product and Services
    • 2.2.4 Nutriben OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Nutriben Recent Developments/Updates
  • 2.3 Ausnutria
    • 2.3.1 Ausnutria Details
    • 2.3.2 Ausnutria Major Business
    • 2.3.3 Ausnutria OPO-containing Infant Formulas Product and Services
    • 2.3.4 Ausnutria OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Ausnutria Recent Developments/Updates
  • 2.4 HERDS
    • 2.4.1 HERDS Details
    • 2.4.2 HERDS Major Business
    • 2.4.3 HERDS OPO-containing Infant Formulas Product and Services
    • 2.4.4 HERDS OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 HERDS Recent Developments/Updates
  • 2.5 Milupa
    • 2.5.1 Milupa Details
    • 2.5.2 Milupa Major Business
    • 2.5.3 Milupa OPO-containing Infant Formulas Product and Services
    • 2.5.4 Milupa OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Milupa Recent Developments/Updates
  • 2.6 Shanxi Yatai
    • 2.6.1 Shanxi Yatai Details
    • 2.6.2 Shanxi Yatai Major Business
    • 2.6.3 Shanxi Yatai OPO-containing Infant Formulas Product and Services
    • 2.6.4 Shanxi Yatai OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Shanxi Yatai Recent Developments/Updates
  • 2.7 Beingmate
    • 2.7.1 Beingmate Details
    • 2.7.2 Beingmate Major Business
    • 2.7.3 Beingmate OPO-containing Infant Formulas Product and Services
    • 2.7.4 Beingmate OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Beingmate Recent Developments/Updates
  • 2.8 Abbott
    • 2.8.1 Abbott Details
    • 2.8.2 Abbott Major Business
    • 2.8.3 Abbott OPO-containing Infant Formulas Product and Services
    • 2.8.4 Abbott OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Abbott Recent Developments/Updates
  • 2.9 Brightdairy
    • 2.9.1 Brightdairy Details
    • 2.9.2 Brightdairy Major Business
    • 2.9.3 Brightdairy OPO-containing Infant Formulas Product and Services
    • 2.9.4 Brightdairy OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Brightdairy Recent Developments/Updates
  • 2.10 Feihe
    • 2.10.1 Feihe Details
    • 2.10.2 Feihe Major Business
    • 2.10.3 Feihe OPO-containing Infant Formulas Product and Services
    • 2.10.4 Feihe OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Feihe Recent Developments/Updates
  • 2.11 Wyeth Nutrition
    • 2.11.1 Wyeth Nutrition Details
    • 2.11.2 Wyeth Nutrition Major Business
    • 2.11.3 Wyeth Nutrition OPO-containing Infant Formulas Product and Services
    • 2.11.4 Wyeth Nutrition OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Wyeth Nutrition Recent Developments/Updates
  • 2.12 Deloraine
    • 2.12.1 Deloraine Details
    • 2.12.2 Deloraine Major Business
    • 2.12.3 Deloraine OPO-containing Infant Formulas Product and Services
    • 2.12.4 Deloraine OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Deloraine Recent Developments/Updates
  • 2.13 Yili
    • 2.13.1 Yili Details
    • 2.13.2 Yili Major Business
    • 2.13.3 Yili OPO-containing Infant Formulas Product and Services
    • 2.13.4 Yili OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Yili Recent Developments/Updates
  • 2.14 Kabrita
    • 2.14.1 Kabrita Details
    • 2.14.2 Kabrita Major Business
    • 2.14.3 Kabrita OPO-containing Infant Formulas Product and Services
    • 2.14.4 Kabrita OPO-containing Infant Formulas Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Kabrita Recent Developments/Updates

3 Competitive Environment: OPO-containing Infant Formulas by Manufacturer

  • 3.1 Global OPO-containing Infant Formulas Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global OPO-containing Infant Formulas Revenue by Manufacturer (2021-2026)
  • 3.3 Global OPO-containing Infant Formulas Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of OPO-containing Infant Formulas by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 OPO-containing Infant Formulas Manufacturer Market Share in 2025
    • 3.4.3 Top 6 OPO-containing Infant Formulas Manufacturer Market Share in 2025
  • 3.5 OPO-containing Infant Formulas Market: Overall Company Footprint Analysis
    • 3.5.1 OPO-containing Infant Formulas Market: Region Footprint
    • 3.5.2 OPO-containing Infant Formulas Market: Company Product Type Footprint
    • 3.5.3 OPO-containing Infant Formulas Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global OPO-containing Infant Formulas Market Size by Region
    • 4.1.1 Global OPO-containing Infant Formulas Sales Quantity by Region (2021-2032)
    • 4.1.2 Global OPO-containing Infant Formulas Consumption Value by Region (2021-2032)
    • 4.1.3 Global OPO-containing Infant Formulas Average Price by Region (2021-2032)
  • 4.2 North America OPO-containing Infant Formulas Consumption Value (2021-2032)
  • 4.3 Europe OPO-containing Infant Formulas Consumption Value (2021-2032)
  • 4.4 Asia-Pacific OPO-containing Infant Formulas Consumption Value (2021-2032)
  • 4.5 South America OPO-containing Infant Formulas Consumption Value (2021-2032)
  • 4.6 Middle East & Africa OPO-containing Infant Formulas Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 5.2 Global OPO-containing Infant Formulas Consumption Value by Type (2021-2032)
  • 5.3 Global OPO-containing Infant Formulas Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 6.2 Global OPO-containing Infant Formulas Consumption Value by Application (2021-2032)
  • 6.3 Global OPO-containing Infant Formulas Average Price by Application (2021-2032)

7 North America

  • 7.1 North America OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 7.2 North America OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 7.3 North America OPO-containing Infant Formulas Market Size by Country
    • 7.3.1 North America OPO-containing Infant Formulas Sales Quantity by Country (2021-2032)
    • 7.3.2 North America OPO-containing Infant Formulas Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 8.2 Europe OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 8.3 Europe OPO-containing Infant Formulas Market Size by Country
    • 8.3.1 Europe OPO-containing Infant Formulas Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe OPO-containing Infant Formulas Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific OPO-containing Infant Formulas Market Size by Region
    • 9.3.1 Asia-Pacific OPO-containing Infant Formulas Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific OPO-containing Infant Formulas Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 10.2 South America OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 10.3 South America OPO-containing Infant Formulas Market Size by Country
    • 10.3.1 South America OPO-containing Infant Formulas Sales Quantity by Country (2021-2032)
    • 10.3.2 South America OPO-containing Infant Formulas Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa OPO-containing Infant Formulas Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa OPO-containing Infant Formulas Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa OPO-containing Infant Formulas Market Size by Country
    • 11.3.1 Middle East & Africa OPO-containing Infant Formulas Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa OPO-containing Infant Formulas Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 OPO-containing Infant Formulas Market Drivers
  • 12.2 OPO-containing Infant Formulas Market Restraints
  • 12.3 OPO-containing Infant Formulas Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of OPO-containing Infant Formulas and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of OPO-containing Infant Formulas
  • 13.3 OPO-containing Infant Formulas Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 OPO-containing Infant Formulas Typical Distributors
  • 14.3 OPO-containing Infant Formulas Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global OPO-containing Infant Formulas market size was valued at US$ 1149 million in 2025 and is forecast to a readjusted size of US$ 1599 million by 2032 with a CAGR of 4.9% during review period.
    OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
    This report is a detailed and comprehensive analysis for global OPO-containing Infant Formulas market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global OPO-containing Infant Formulas market size and forecasts, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
    Global OPO-containing Infant Formulas market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
    Global OPO-containing Infant Formulas market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K MT), and average selling prices (USD/MT), 2021-2032
    Global OPO-containing Infant Formulas market shares of main players, shipments in revenue ($ Million), sales quantity (K MT), and ASP (USD/MT), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for OPO-containing Infant Formulas
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global OPO-containing Infant Formulas market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    OPO-containing Infant Formulas market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Cow Milk Formula
    Goat Milk Formula
    Market segment by Application
    0 - 6 Month
    6 - 12 Month
    12 - 36 Month
    Major players covered
    BiosTime
    Nutriben
    Ausnutria
    HERDS
    Milupa
    Shanxi Yatai
    Beingmate
    Abbott
    Brightdairy
    Feihe
    Wyeth Nutrition
    Deloraine
    Yili
    Kabrita
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe OPO-containing Infant Formulas product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of OPO-containing Infant Formulas, with price, sales quantity, revenue, and global market share of OPO-containing Infant Formulas from 2021 to 2026.
    Chapter 3, the OPO-containing Infant Formulas competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the OPO-containing Infant Formulas breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and OPO-containing Infant Formulas market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of OPO-containing Infant Formulas.
    Chapter 14 and 15, to describe OPO-containing Infant Formulas sales channel, distributors, customers, research findings and conclusion.

    Buy now